Previous studies have shown that PVR molecules expressed on the surface of tumor cells can bind to TIGIT on the surface of NK cells, which lead to inhibitory signals in NK cells, and then reduce the function of NK cells to kill tumor cells (8, 41, 42). The gene discussed is TIGIT; the disease is neoplasm.